GAO to investigate whether White House influenced COVID-19 vaccine approval process, pandemic response

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

The independent watchdog said it would not begin to perform the examination for “about three months.” The project has been assigned to Nikki Clowers, the managing director of GAOs health care team..

The Government Accountability Office will probe whether the White House disrupted FDA and CDC operations throughout the countrys pandemic action, a group of Senate Democrats announced Oct. 20.

GAO accepted the demand in an Oct. 16 letter, composing it would “examine whether the CDC and FDAs scientific integrity and interactions policies have been broken and whether those policies are being executed as planned to ensure scientific integrity.”.

Sens. Elizabeth Warren, D-Mass., Gary Peters D-Mich., and Patty Murray, D-Wash., formally requested the investigation in an Oct. 8 letter in which they cite several supposed examples of White House appointees influencing the FDA and CDC to minimize the pandemics severity.

More short articles on pharmacy:7 things to understand about Pfizers COVID-19 vaccine timelineCOVID-19 vaccine acceptance reaches historic level of distrust, poll findsFDA advisory panel to publicly discuss COVID-19 vaccine approval procedure.

Katie Adams –
Tuesday, October 20th, 2020